Article

CauReL: Dynamic Counterfactual Learning for Precision Drug Repurposing in Alzheimer's Disease

2025-12-15

Abstract excerpt

<title>Abstract</title> <p>Alzheimer’s disease has few effective therapies, and decades of amyloid- and tau-focused trials have delivered only modest benefit with substantial toxicity. Drug repurposing using real-world data offers a faster and lower-risk route to new treatments, yet current approaches typically average effects across populations, model disease onset and progression separately, and provide little...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: dd1d0f47-2766-5b73-8638-7e99f5e0630d
DOI: 10.21203/rs.3.rs-8206648/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

CauReL: Dynamic Counterfactual Learning for Precision Drug Repurposing in Alzheimer's DiseaseDOI 10.21203/rs.3.rs-8206648/v1Read

Medication-Wide Association Study of Alzheimer’s Disease and Related Dementias: Identifying Drug Candidates from Electronic Health Records through Explainable AISemantic proximity Read

High-Throughput Clinical Trial Emulation with Real World Data and Machine Learning: A Case Study of Drug Repurposing for Alzheimer’s DiseaseSemantic proximity Read

SPLIT: Safety Prioritization for Long COVID Drug Repurposing via a Causal Integrated Targeting FrameworkSemantic proximity Read

Leveraging Generative AI to Prioritize Drug Repurposing Candidates: Validating Identified Candidates for Alzheimer’s Disease in Real-World Clinical DatasetsSemantic proximity Read

Identifying incident dementia by applying machine learning to a very large administrative claims datasetSemantic proximity Read

Integrating explainable AI with multiomics systems biology and EHR data mining for personalized drug repurposing in Alzheimer’s diseaseSemantic proximity Read

Foundational model aided automatic high-throughput drug screening using self-controlled cohort studySemantic proximity Read

Leveraging Generative AI to Prioritize Drug Repurposing Candidates: Validating Identified Candidates for Alzheimer's Disease in Real-World Clinical DatasetsSemantic proximity Read

DeepDrug2: A Germline-focused Graph Neural Network Framework for Alzheimer’s Drug Repurposing Validated by Electronic Health RecordsSemantic proximity Read

Knowledge-guided Deep Temporal Clustering for Alzheimer’s Disease Subtypes in Completed Clinical TrialsSemantic proximity Read

Synthesize Heterogeneous Biological Knowledge via Representation Learning for Alzheimer’s Disease Drug RepurposingSemantic proximity Read

Glucagon-like peptide-1 receptor agonist initiation and risk of clinically recorded Alzheimer's disease-type dementia in older adults with type 2 diabetes: a target trial emulation using causal machine learningSemantic proximity Read